NCT00855101View on ClinicalTrials.gov

A Pharmacokinetic And Safety Study Of Voriconazole In Healthy Male And Female Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Healthy Volunteers

Interventions

DRUG

voriconazole

6 mg/kg IV q12h on Day 1, and 4 mg/kg IV q12h on Days 2-7, then switch to 200 mg oral tablet q12h on Days 8-14.

Trial Locations (1)

1070

Pfizer Investigational Site, Brussels

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY